Home > HBMK Financials

Hubei Minkang Pharmaceutical financials at a glance

Year	Year		2011	2012	2013	2014	2015	2017	2018	2019	2020	2009	2010	2021
Rev.	Revenue		12.55M	13.92M	14.74M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	11.65M	15.01M	0.00M
GM %	Gross Margin %		47.83%	48.54%	42.66%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	50.62%	54.25%	0.00%
OM	Operating Margin		0.84%	7.36%	0.28%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.92%	23.19%	0.00%
EPS	Earnings Per Share		0.00	0.00	0.00	0.00	0.00
Div.	Dividends		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PR %	Payout Ratio %		0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares		43.05m	44.18m	52.19m	52.19m	52.19m	52.19m	52.19m	52.19m	0m	0m	0m	0m
OCF	Operating Cash Flow		-0.75M	2.01M	0.91M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.37M	3.68M	0.00M
FCF	Free Cash Flow		-1.07M	1.62M	0.71M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	1.00M	3.43M	0.00M
FCFS	Free Cash Flow Per Share		-0.03	0.04	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.10	0.00

© Kit Invest S.L - StockForecast 2022. All rights reserved. Calle Alemania 3, 35100 San Bartolome de Tirajana, Spain | CIF: B57640591 Contact at [email protected]

StockForecast enables investors to make better investment decisions by providing financial data and objective market analysis. StockForecast has the objective information you need to analyze stocks and currencies. StockForecast is not a personal financial advisor and does not make recommendations or offers to buy or sell securities or currencies.